ESCAPE TRIAL Sites:
The study included 22 sites worldwide and patients in the U.S., U.K., Ireland and South Korea. Canada had 11 participating hospitals and enrolled two-thirds of the patients.
Foothills Medical Centre | Calgary, Alta.
Royal University Hospital | Saskatoon, Sask.
Colorado Neurological Institute | Denver, Colo.
St. Michael's Hospital | Toronto, Ont.
UPMC Medical Centre | Pittsburgh, Penn.
Queen Elizabeth II HSC | Halifax, N.S.
Toronto Western Hospital | Toronto, Ont.
University of Alberta Hospital | Edmonton, Alta.
Chattanooga Center for Neurologic Research | Chattanooga, Tenn.
CHUM-Hospital Notre-Dame | Montreal, Que.
MUSC-Medical University of South Carolina | Charleston, S.C.
Sunnybrook Health Sciences Centre | Toronto, Ont.
Ottawa Hospital | Ottawa, Ont.
London Health Sciences Centre | London, Ont.
McGill University (MNI) | Montreal, Que.
Beaumont Hospital | Dublin, Ireland
Abington Memorial Hospital | Abington, Penn.
Royal Victoria Hospital | Belfast, N. Ireland
Yonsei University (Severance Hospital) | Seoul, South Korea
Samsung Medical Centre | Seoul, South Korea
Keimyung University (Dongsan Medical Centre) | Daegu, South Korea
Temple University Hospital | Philadelphia, Penn.